CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 78 filers reported holding CASCADIAN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,865,000 | +2.3% | 2,125,480 | +13.1% | 0.00% | – |
| Q3 2017 | $7,689,000 | +17.1% | 1,880,040 | +6.4% | 0.00% | – |
| Q2 2017 | $6,567,000 | +11.4% | 1,767,681 | +24.1% | 0.00% | – |
| Q1 2017 | $5,895,000 | +108.2% | 1,423,843 | +116.7% | 0.00% | – |
| Q4 2016 | $2,832,000 | – | 657,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 53 | $0 | 0.00% |